Aisling Capital’s Lombard Medical, Inc. EVAR Stock Holding History

Aisling Capital’s Portfolio EVAR Stock Details EVAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-443,182	Closed	-$417K	–	19
2016 Q3	$417K	Sell	443,182 -443,181	-50%	-$470K	0.09%	20
2016 Q2	$966K	Hold	886,363	–	–	0.23%	20
2016 Q1	$931K	Hold	886,363	–	–	0.19%	20
2015 Q4	$1.2M	Hold	886,363	–	–	0.21%	20
2015 Q3	$3.16M	Hold	886,363	–	–	0.56%	19
2015 Q2	$3.9M	Hold	886,363	–	–	0.58%	17
2015 Q1	$3.57M	Hold	886,363	–	–	0.47%	18
2014 Q4	$5.76M	Hold	886,363	–	–	0.87%	17
2014 Q3	$6.82M	Hold	886,363	–	–	1.32%	16
2014 Q2	$6.38M	Buy	+886,363	New	+$7.22M	1.84%	12

Other funds holding EVAR

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aisling Capital's EVAR Position: Q4 2016 in Review

Aisling Capital sold out of Lombard Medical, Inc. (EVAR) in Q4 2016, closing a stake of 443,182 shares — an estimated $417K sold.

Aisling Capital first reported a position in EVAR in Q2 2014 and held it in 10 quarters. The position peaked at $6.82M in Q3 2014. 9 funds tracked by Wall St. Rank hold EVAR as of Q4 2016.

Aisling Capital reported no remaining Lombard Medical, Inc. position as of Q4 2016 after selling out during the quarter.
Aisling Capital sold 443,182 Lombard Medical, Inc. shares in Q4 2016, an estimated $417K.
Aisling Capital first reported a position in Lombard Medical, Inc. in Q2 2014 and held it in 10 quarters.
Aisling Capital's Lombard Medical, Inc. position peaked at $6.82M in Q3 2014.
9 funds tracked by Wall St. Rank held Lombard Medical, Inc. as of Q4 2016.

Based on Aisling Capital's 13F filing for Q4 2016, filed 13 Feb 2017.